Media Interviews:

Joiner, W. (2020, September 28). If psychedelics are going mainstream will they be accessible to everyone? The Independent.

Joiner, W. (2020, September 21). Who Will Benefit From Psychedelic Medicine? The Washington Post Magazine.

Moore, J. & Buller, K., (2020, September 01). Ketamine Therapy Through a Culturally Responsible Lens. Psychedelics Today.

Lawlor, S. (2020, August 11). What is psychedelic therapy? Common trends, practices, and foundations in the field. Psychedelics Today. 

Mwale, S. (2020, July 13). Empathic innovation: Building solutions for people, not people for solutions. Health Venture.

Luse, B. (2019, February 4). Blue Pill. The Nod. Gimlet Media.

Lekhtman, A. (2018, December 4). The Burgeoning Psychedelics Movement Still Excludes Women and People of Color. Filter.

Ofgang, E. (2018, October 22). Psychedelic Drugs Show Promise For Treatment of PTSD. Connecticut Magazine.

Articles:

Williams, M. T., Reed, S., & George, J. (in press). Culture and psychedelic psychotherapy: Ethnic and racial themes from three Black women therapists. Journal of Psychedelic Studies. doi: 10.1556/2054.2020.00137

 

Williams, M. T., Reed, S., & Aggarwal, R. (2020). Culturally-informed research design issues in a study for MDMA-assisted psychotherapy for posttraumatic stress disorder. Journal of Psychedelic Studies, 4(1), 40–50. doi: 10.1556/2054.2019.016

Sloshower, J., Guss, J., Krause, R., Wallace, R., Williams, M., Reed, S., & Skinta, M. (2020). Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame. Journal of Contextual Behavioral Science, 15, 12-19.

Reed, S. (2020, June 19). The shadows you won't face. North Star.

Reed, S. (2019, January 11). The damage of white feminism: An Anecdote. Chacruna Institute.

Reed, S. (2019). Health equity in psychedelic medicine: Advancing practices for people of color. Multidisciplinary Association for Psychedelic Studies (MAPS) Bulletin, 29(1), 50–51.

Selected Presentations:

Slowshower, J., Ramos, M., Reed, S., Greer, C. (2020, November 19). The promise and perils of psychedelic therapy: Historical and contemporary social justice perspectives. RebPsych 2020: Decolonizing mental healh. Yale University, New Haven, CT.

Reed, S. (2020, September 02). Ketamine therapy: Promoting access and cultural responsibility. Empowering therapists of color as psychedelics go mainstream. Chacruna Institute.

Reed, S. (2020, July 29). Cultural considerations in mdma-assisted psychotherapy for ptsd. Yale psychedelic science group webinar series on psychedelics & social justice. Yale University, New Haven, CT.

Reed, S. (2019, August 10-17). MDMA Conference for Therapists and Communities of Color. Workshop lecturer. Louisville, KY.

Williams, M. T., Wetterneck, C. T., Reed, S., Siu, W., Ching, T. & George, J. (2018, November 8-10). Psychedelic Therapy for PTSD in People of Color. Panel presentation for 34th Annual Meeting of the International Society for Traumatic Stress Studies, Washington, DC.

Reed, S. (2018, November 19). Ego Dissolution, Racial Wounds, and the Female Body: A Journey Home. Women and Psychedelics Conference. California Institute of Integral Studies, San Francisco, CA.

Reed, S. (2018, June). Ego Dissolution, Racial Wounds, and the Female Body: Stories from a Black Woman's Cellular Membrane. AFTA Annual Conference, June 21-23, 2018, Austin, TX.

Siu, W., & Reed, S. (2018, April 17). MDMA-Assisted Psychotherapy: “Our Experiences as Subjects in an FDA-Approved Clinical Trial.” University of Connecticut.

Ching, T. H. W., Williams, M. T., Kisicki, Reed, S. J., & George, J. (2017, November). MDMA-Assisted Psychotherapy for Treatment-Resistant PTSD: MAPS-Sponsored Phase 2 Findings & Cultural Considerations for Phase 3 Trials. Poster session at the 51st Annual Convention of the Association of Behavioral and Cognitive Therapies, San Diego, CA.